Variables | Total n = 54 | Experimental group n = 27 | Control group n = 27 | p value |
---|---|---|---|---|
Mean age (years) | 63.72 ± 10.63 | 62.81 ± 11.29 | 64.63 ± 10.05 | 0.536 |
Gender | Â | Â | Â | 0.163 |
 Male | 33 | 19 (70.37 %) | 14 (51.85 %) |  |
 Female | 21 | 8 (29.63 %) | 13 (48.15 %) |  |
Mean tumor diameter (cm) | 4.31 ± 1.57 | 4.31 ± 1.67 | 4.31 ± 1.48 | 0.986 |
Tumor differentiation | Â | Â | Â | 0.738 |
 Well | 13 | 6 (22.22 %) | 7 (25.93 %) |  |
 Moderately | 33 | 16 (59.26 %) | 17 (62.96 %) | |
 Poorly | 8 | 5 (18.52 %) | 3 (11.11 %) | |
Tumor location | Â | Â | Â | 0.726 |
 Transverse colon | 8 | 4 (14.81 %) | 4 (14.81 %) |  |
 Right hemicolon | 14 | 9 (33.33 %) | 5 (18.52 %) | |
 Left hemicolon | 11 | 5 (18.52 %) | 6 (22.22 %) | |
 Sigmoid colon | 11 | 4 (14.81 %) | 7 (25.93 %) | |
 Rectum | 10 | 5 (18.52 %) | 5 (18.52 %) | |
T stage | Â | Â | Â | 0.775 |
 T1 | 3 | 1 (3.70 %) | 2 (7.41 %) |  |
 T2 | 19 | 9 (33.33 %) | 10 (37.04 %) | |
 T3 | 32 | 17 (62.96 %) | 15 (55.56 %) |  |
N stage | Â | Â | Â | 0.588 |
 N0 | 37 | 17 (62.96 %) | 20 (74.07 %) |  |
 N1 | 11 | 7 (25.93 %) | 4 (14.81 %) | |
 N2 | 6 | 3 (11.11 %) | 3 (11.11 %) | |
Dukes stage | Â | Â | Â | 0.661 |
 A | 16 | 7 (25.93 %) | 9 (33.33 %) |  |
 B | 21 | 10 (37.04 %) | 11 (40.74 %) | |
 C | 17 | 10 (37.04 %) | 7 (25.93 %) | |
Clinical stage | Â | Â | Â | 0.475 |
 I | 17 | 8 (29.63 %) | 9 (33.33 %) |  |
 II | 21 | 9 (33.33 %) | 12 (44.44 %) |  |
 III | 16 | 10 (37.04 %) | 6 (22.22 %) |  |